Escherichia coli-derived recombinant human glycosylation inhibiting factor (rhGIF) contains three cysteine residues (Cys-57, -60, and -81). All SH groups in the cysteine residues are free, and the GIF molecule had no biologic activity. Carboxymethylation of the SH group of Cys-60 in the molecule resulted in the generation of bioactivity, although the activity of the carboxymethylated GIF was 10-to 20-fold less than that of suppressor T cell (Ts)-derived GIF. However, treatment of the inactive rhGIF with ethylmercurithiosalicylate or 5,5-dithiobis(2-nitrobenzoic acid) (DTNB) resulted in the generation of derivatives whose bioactivity was comparable to that of the Ts-derived bioactive GIF. The activity of these derivatives was lost by treatment with DTT. Isolation and chemical analysis of the DTNB-treated GIF derivative revealed that binding the 5-thio-2-nitrobenzoic acid group with Cys-60 was responsible for the generation of the highly bioactive derivative. Inactive cytosolic GIF from mammalian cells could also be converted to bioactive derivative by treatment with the SH reagent, while Ts-derived bioactive GIF was inactivated by DTT. These results, together with an x-ray crystal structure of GIF molecules, strongly suggest that the generation of bioactivity of GIF in Ts cells is due to posttranslational modifications that result in conformational changes in the molecule.We have previously described glycosylation inhibiting factor (GIF), a 13-kDa cytokine, as a product of suppressor T (Ts) cells (1, 2) and a subunit of antigen-specific Ts cell factors (3, 4). After molecular cloning of this cytokine, however, we realized that various cell line cells produced the 13-kDa peptide, which reacted with polyclonal antibodies against recombinant GIF (rGIF). Nevertheless, only the peptide secreted by Ts cells demonstrated GIF bioactivity (5). Escherichia coli-derived rGIF was also inactive. It was found that Ts cells contained a substantial quantity of inactive GIF peptide in cytosol (5) and that the amino acid sequence of the inactive peptide was identical to that of the bioactive homologue (6). No difference was detected by SDS͞PAGE analysis among the bioactive GIF, inactive GIF in cytosol, and E. coli-derived rGIF. These findings suggested to us the possibility that generation of bioactive GIF by Ts cells is due to posttranslational modifications of the peptide and that heterogeneity of GIF in bioactivity is due to a conformational transition of the same peptide (5).Deduced amino acid sequence of recombinant GIF indicated that the GIF peptide contains three cysteine residues (Cys-57, -60, and -81) (7). One might expect the formation of an intrachain disulfide bond to change the conformation of GIF molecules. We were also interested in the sequence of Cys-57-Xaa-Xaa-Cys-60, because such a structure may be involved in interprotein association (8). Cysteine residues in the Cys-Xaa-Xaa-Cys sequence may also be involved in the coordination of a metal ion that mediates protein-protein interaction (9). Green and Cham...